Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This appears to be a minor maintenance update with no changes to study content or data visible on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3; the page's content and structure related to the study details remain unchanged.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor build/format update to the study details page without altering its substantive content.SummaryDifference0.1%

- Check48 days agoChange DetectedRecruitment has been closed, as indicated by the new 'No longer looking for participants' note on the study page. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the page footer shows Revision: v3.6.0.SummaryDifference0.4%

- Check55 days agoChange DetectedA new revision label v3.5.5 was added and the previous v3.5.4 was removed, signaling a small release update to the page.SummaryDifference0.1%

- Check76 days agoChange DetectedUpdated the page revision from v3.5.3 to v3.5.4, indicating a minor update to the study page content and its tracking version.SummaryDifference0.1%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.